MAPS 2025 Americas Annual Meeting Annual meeting sessions aligned with MAPS Medical Affairs Competencies Framework provide training oppo ...

Despite announcing strong earnings, Organon & Co.'s ( NYSE:OGN ) stock was sluggish. We did some digging and found ...

Organon Philippines, a women’s health company, recently unveiled its Her Health Finder, an online tool that aims to empower ...

On October 30, 2024, Shanghai Henlius Biotech and Organon announced that the FDA has accepted the Biologic License Application (BLA) for HLX14, a proposed biosimilar to PROLIA/XGEVA (denosumab). In ...

Last night Ward6 picked up another trophy at this year’s PRIME Awards. The agency won Launch of the Year for The PRIME Awards ...

Organon's OGN short percent of float has risen 28.4% since its last report. The company recently reported that it has 12.53 ...

They made the remarks as the international exchange platform, in its seventh edition this year, has attracted many leading ...

International Assets Investment Management LLC increased its holdings in Organon & Co. (NYSE:OGN – Free Report) by 1,851.8% in the third quarter, HoldingsChannel.com reports. The institutional ...

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...

On Tuesday, Organon & Co (OGN) stock saw a decline, ending the day at $16.46 which represents a decrease of $-0.46 or -2.72% from the prior close of $16.92. The stock opened at $16.74 and touched a ...

InProcess-LSP are a young organization, founded in 2014, they have since emerged as providers of groundbreaking process analytical technology for nanoparticle characterization. This article provides a ...

Organon (OGN) announced that the FDA extended by three months the target action date of its review of the supplemental New Drug Application, or ...